IBM Is Down 7%. What History Says About the Recovery

IBM Exits Yellow Zone: What Past 7% Drawdowns Tell Us

International Business Machines Corporation (IBM) is now down 7% from its all-time high as of July 7, 2026, having just exited the yellow zone after approximately 20 days. The Drawdown Severity Score™ has improved to 1.4, placing the stock in the green zone. In 40 comparable prior drops of 5% or more, the stock took an average of 338 days to recover.

As the stock price recovers, we must analyze where its valuation multiples sit within its own historical record. While the price drawdown has moderated, the underlying valuation multiples remain highly elevated compared to the stock's long-term historical trading patterns. Specifically, we look at where the Price-to-Sales (P/S) percentile and the Enterprise Value-to-EBITDA (EV/EBITDA) percentile now sit relative to the company's own historical record since July 3, 2006. Our data shows a distinct contrast: the stock price has experienced a mild pullback, but the valuation multiples remain near the very top of their multi-decade historical ranges.

Current Severity Score and Zone Dynamics

The transition from the yellow zone back to the green zone represents a stabilization in selling pressure. In our framework, the green zone indicates a "Slightly Elevated" risk level, signaling that the asset's price behavior is reverting toward historical norms. When an asset is in the yellow zone, it indicates a moderate disruption where the price deviates more significantly from its recent highs, often prompting tactical investors to closely monitor support levels.

The Drawdown Severity Score™ of 1.4 reflects this return to relative normalcy. This proprietary metric evaluates the velocity, depth, and duration of price declines to classify assets into risk tiers. By crossing back into the green zone, the stock demonstrates that the immediate downward momentum has dissipated, although it has not yet fully erased its peak-to-trough decline.

Historically, zone transitions serve as objective markers of shifting market regimes rather than subjective indicators of sentiment. A move to the green zone suggests that the selling volume has dried up, allowing buyers to establish a firmer price floor. However, an asset remains within the broader drawdown framework until it completely reclaims its previous peak, meaning risk management protocols should remain active.

Valuation Versus Its Own Record

As of 2026-07-06, the Price-to-Sales (P/S) ratio for IBM stands at 4.0, which sits in the 97th percentile of its own daily P/S record since July 3, 2006. This ratio is historically high compared to its historical median of 1.8. Similarly, the Enterprise Value-to-EBITDA (EV/EBITDA) ratio is 20.4, placing it in the 98th percentile of its own daily history since July 3, 2006, well above its historical median of 9.5. This data shows that despite the recent price pullback, the stock's valuation multiples remain near the very top of their historical ranges over the last two decades.

This divergence between a recovering price and exceptionally high valuation percentiles highlights the impact of multiple expansion. When an asset's valuation multiples sit in such high percentiles relative to its own history, it indicates that investors are paying a significant premium for each dollar of sales and earnings compared to historical averages. This historical context is not a recommendation to buy or sell, but rather an analytical observation that the stock's current pricing structure is highly valued relative to its own historical baseline, even after experiencing a mild price correction.

Historical Comparison and Recovery Pathways

To understand how the current recovery might unfold, we examine IBM's extensive historical dataset. Since July 2006, the stock has experienced a total of 154 historical drawdown events. The average maximum drawdown across all these events was -5.2%, with an average drawdown duration of 93 days.

However, when we isolate more severe pullbacks of 5% or more, a different pattern emerges. The stock has dropped by 5% or more from its peak a total of 40 times. The average duration of these comparable drops is 338 days, reflecting a much longer period of consolidation and recovery.

It is critical to note that the 338-day average recovery time for drops of 5% or more carries high variance and is heavily skewed by major macroeconomic regimes. For example, prolonged periods of market distress, such as the 2008 global financial crisis or the 2020 pandemic-induced downturn, significantly drag up the average duration. Conversely, idiosyncratic pullbacks during strong bull markets often resolve much faster, highlighting that historical averages should be interpreted as a guide to potential variance rather than a deterministic timeline.

What's Driving the Recent Price Movement

Several recent fundamental and market developments have influenced the stock's recent price action. According to TradingView, the stock experienced upward momentum following a quantum computing breakthrough achieved in collaboration with U.S. scientists. This technological milestone renewed investor interest in the company's long-term research and development pipeline.

Additionally, reports from Trefis highlighted a strong short-term rally, noting that the stock rocketed 16% during a 6-day winning streak. This rapid price appreciation helped pull the stock out of its deeper drawdown territory and facilitated the transition back to the green zone.

Meanwhile, institutional activity has shown mixed signals. According to MarketBeat, Swedbank AB reduced its position in the company, while Hoey Investments Inc. purchased additional shares, illustrating the ongoing debate among institutional managers regarding the stock's valuation at these levels. Investors are also looking forward to upcoming corporate milestones, with Barchart.com reminding market participants to mark their calendars for July 22, a key date for the company's next earnings release.

What to Watch Moving Forward

As IBM continues to trade within the green zone, investors should monitor key technical and fundamental markers to assess whether the recovery will hold. The Drawdown Severity Score™ of 1.4 indicates a relatively stable regime, but any renewed downward pressure could quickly push the score back toward the yellow threshold. Specifically, a break below the recent support levels established during the 19-day drawdown would signal a potential return to elevated risk zones.

On the fundamental side, tracking the movement of valuation percentiles is crucial. With both the P/S and EV/EBITDA ratios sitting near historical highs relative to the company's own history, future earnings reports will be critical. If revenue and EBITDA growth do not expand to justify these multiples, the stock may face valuation compression, even if the price remains stable.

Monitoring whether these valuation percentiles begin to revert toward their historical medians or continue to expand will help clarify whether the current price stabilization is supported by fundamental growth. We will continue to track these proprietary metrics daily to provide objective updates on the stock's risk profile.